Yuichiro Hagiya

1.7k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Yuichiro Hagiya is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yuichiro Hagiya has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Yuichiro Hagiya's work include Photodynamic Therapy Research Studies (16 papers), Nanoplatforms for cancer theranostics (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Yuichiro Hagiya is often cited by papers focused on Photodynamic Therapy Research Studies (16 papers), Nanoplatforms for cancer theranostics (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Yuichiro Hagiya collaborates with scholars based in Japan, United States and Netherlands. Yuichiro Hagiya's co-authors include Shun‐ichiro Ogura, Toshihisa Ishikawa, Hiromi Kataoka, Shigenobu Yano, Takashi Joh, Makoto Obata, Atsushi Ikeda, Shiho Hirohara, Mamoru Tanaka and Tohru Tanaka and has published in prestigious journals such as PLoS ONE, Scientific Reports and Pharmaceutical Research.

In The Last Decade

Yuichiro Hagiya

27 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current states and future views in photodynamic therapy

2011 456 citations Yuichiro Hagiya, Shun‐ichiro Ogura et al. profile →

Peers

Countries citing papers authored by Yuichiro Hagiya

Since Specialization

Citations

This map shows the geographic impact of Yuichiro Hagiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Hagiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Hagiya more than expected).

Fields of papers citing papers by Yuichiro Hagiya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Hagiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Hagiya. The network helps show where Yuichiro Hagiya may publish in the future.

Co-authorship network of co-authors of Yuichiro Hagiya

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Hagiya. A scholar is included among the top collaborators of Yuichiro Hagiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Hagiya. Yuichiro Hagiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Rong Zhang, Tsuyoshi Kobayashi, Hirotake Tsukamoto, Tianyi Liu, (unknown), Yuichiro Hagiya, (unknown), Satoshi Fukushima, Seiji Okada, Alimjan Idiris, Shin Kaneko, Tetsuya Nakatsura, Hideki Ohdan, Yasushi Uemura	10
2	5-Aminolevulinic acid regulates the immune response in LPS-stimulated RAW 264.7 macrophages 2018 ·BMC Immunology ·Yuta Sugiyama, (unknown), Yuichiro Hagiya, Motowo Nakajima, Tohru Tanaka, Shun‐ichiro Ogura	28
3	Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation 2017 ·Scientific Reports ·Wenqian Wang, Kouichi Tabu, Yuichiro Hagiya, Yuta Sugiyama, (unknown), (unknown), Shun‐ichiro Ogura, Tetsuya Taga	47
4	Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy 2016 ·Scientific Reports ·(unknown), (unknown), Tatsuya Kobayashi, (unknown), Kentaro Matsumoto, Yuichiro Hagiya, Keiji Inoue, Taro Shuin, Motowo Nakajima, Tohru Tanaka, Shun‐ichiro Ogura	44
5	The Effect of Iron Ion on the Specificity of Photodynamic Therapy with 5-Aminolevulinic Acid 2015 ·PLoS ONE ·(unknown), Hideo Fukuhara, Keiji Inoue, Taro Shuin, Yuichiro Hagiya, Motowo Nakajima, Tohru Tanaka, Shun‐ichiro Ogura	29
6	Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: Tumor cell response to hypoxia 2015 ·Photodiagnosis and Photodynamic Therapy ·Kentaro Matsumoto, Yuichiro Hagiya, Yoshio Endo, Motowo Nakajima, Masahiro Ishizuka, Tohru Tanaka, Shun‐ichiro Ogura	32
7	The effects of the heme precursor 5‐aminolevulinic acid (ALA) on REV‐ERBα activation 2014 ·FEBS Open Bio ·(unknown), Yuichiro Hagiya, Motowo Nakajima, Masahiro Ishizuka, Tohru Tanaka, Shun‐ichiro Ogura	6
8	Access to a novel near-infrared photodynamic therapy through the combined use of 5-aminolevulinic acid and lanthanide nanoparticles 2013 ·Photodiagnosis and Photodynamic Therapy ·Atsushi Shimoyama, (unknown), Yu Liu, Shun‐ichiro Ogura, Yuichiro Hagiya, Kiwamu Takahashi, Katsushi Inoue, Tohru Tanaka, Yasutoshi Murayama, Eigo Otsuji, Akihiro Ohkubo, Hideya Yuasa	17
9	The heme precursor 5-aminolevulinic acid disrupts the Warburg effect in tumor cells and induces caspase-dependent apoptosis 2013 ·Oncology Reports ·Yuta Sugiyama, Yuichiro Hagiya, Motowo Nakajima, Masahiro Ishizuka, Tohru Tanaka, Shun‐ichiro Ogura	24
10	Improvement of Tumor Localization of Photosensitizers for Photodynamic Therapy and Its Application for Tumor Diagnosis 2012 ·Current Topics in Medicinal Chemistry ·Shun‐ichiro Ogura, Yuichiro Hagiya, Kenji Tabata, Toshiaki Kamachi, Ichiro Okura	10
11	Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro 2012 ·Photodiagnosis and Photodynamic Therapy ·Yuichiro Hagiya, Yoshio Endo, Yutaka Yonemura, Kiwamu Takahashi, Masahiro Ishizuka, Fuminori Abe, Tohru Tanaka, Ichiro Okura, Motowo Nakajima, Toshihisa Ishikawa, Shun‐ichiro Ogura	98
12	Improvement of aminolevulinic acid (ALA)-mediated photodynamic diagnosis using n-propyl gallate 2012 ·Photodiagnosis and Photodynamic Therapy ·Tomohisa Hirano, Yuichiro Hagiya, Hideo Fukuhara, Keiji Inoue, Taro Shuin, Kentaro Matsumoto, Katsushi Inoue, Tohru Tanaka, Ichiro Okura, Shun‐ichiro Ogura	9
13	Porphyrins in urine after administration of 5-aminolevulinic acid as a potential tumor marker 2011 ·Photodiagnosis and Photodynamic Therapy ·Masahiro Ishizuka, Yuichiro Hagiya, (unknown), (unknown), Kenji Tabata, Toshiaki Kamachi, Kiwamu Takahashi, Fuminori Abe, Tohru Tanaka, Motowo Nakajima, Shun‐ichiro Ogura, Ichiro Okura	21
14	The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver 2011 ·BMC Research Notes ·Shun‐ichiro Ogura, Kouji Maruyama, Yuichiro Hagiya, Yuta Sugiyama, Kyoko Tsuchiya, Kiwamu Takahashi, Fuminori Abe, Kenji Tabata, Ichiro Okura, Motowo Nakajima, Tohru Tanaka	74
15	Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis 2010 ·Advances in Pharmacological Sciences ·Toshihisa Ishikawa, Hiroshi Nakagawa, Yuichiro Hagiya, Naosuke Nonoguchi, Shin‐Ichi Miyatake, Toshihiko Kuroiwa	42
16	Transport−Metabolism Interplay: LXRα-Mediated Induction of Human ABC Transporter ABCC2 (cMOAT/MRP2) in HepG2 Cells 2009 ·Molecular Pharmaceutics ·(unknown), Hiroshi Nakagawa, Yuichiro Hagiya, (unknown), Toshihisa Ishikawa	4
17	Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2: development ofin vitrohigh-speed screening systems 2008 ·Expert Opinion on Drug Metabolism & Toxicology ·Ai Tamura, Ran An, Yuichiro Hagiya, Kazuyuki Hoshijima, Takashi Yoshida, Kenta Mikuriya, Toshihisa Ishikawa	13
18	MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions 2008 ·Xenobiotica ·Yu Toyoda, Yuichiro Hagiya, (unknown), Kazuyuki Hoshijima, M. Tien Kuo, Toshihisa Ishikawa	95
19	Cellular Phototoxicity Evoked Through the Inhibition of Human ABC Transporter ABCG2 by Cyclin-dependent Kinase Inhibitors In vitro 2008 ·Pharmaceutical Research ·Ran An, Yuichiro Hagiya, Ai Tamura, Shanshan Li, Hikaru Saito, (unknown), Toshihisa Ishikawa	29
20	Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. 2007 ·PubMed ·(unknown), Hiroshi Nakagawa, Ivy Chung, Yuichiro Hagiya, Kazuyuki Hoshijima, Noriko Noguchi, Macus Tien Kuo, Toshihisa Ishikawa	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact